World Vaccine Congress DC
April 21-24, 2025 | Booth 501
Walter E Washington Convention Center
Washington, DC

Hear from Apiject Experts

Ed Kelley, PhD
Chief Global Health Officer
The New Access Paradigm: Jump Starting Local Manufacturing & Community Delivery for Global Health Markets
April 21 | 2:00 p.m.

Bo Kowalczyk
Chief Commercial Officer
Expanding Access and Reducing Costs: How
Distributed Manufacturing of the BFS Prefilled Drug Delivery Platform Enhances Logistics
April 23 | 2:55 p.m.
Expanded Market Access
Apiject’s advancements in Blow-Fill-Seal (BFS) aseptic packaging enhance cost-effectiveness and reliability in fill-finish processes for sterile liquids and pave the way for injectables to reach most patients in various markets through a prefilled, ready-to-use format.
Sustainability
Apiject’s devices are designed with less plastic than a standard syringe and avoids high energy and high carbon footprint manufacturing processes associated with glass vials and prefilled syringes.
Prefilled Format at Single Vial Cost
At Apiject, we combine the manufacturing technologies of BFS and injection molding to enable drugs and vaccines to be fill-finished in a prefilled injectable format at any scale and at a lower total cost of dose delivery.
Schedule a Meeting
Enter your information and we will reach out to schedule a meeting

Apiject is transforming drug delivery wherever injections happen. Our Prefilled Drug Delivery System combines the benefits of prefilled with the scale and economics of glass vial formats. We achieve this combination of quality and affordability by syringes bringing together two globally trusted technologies, Blow-Fill-Seal and high precision plastic molding.
Transitioning your Drug Products or Vaccines into a Prefilled Blow-Fill-Seal Delivery Device
Topics in this presentation include:
- Technical considerations for material compatibility, process parameters and drug stability
- How prototyping and feasibility studies can resolve potential BFS challenges
- Key factors in formulation, packaging, and regulatory filings for BFS products
The Apiject Platform
Meet with Our Team
Enter your information and we will reach out to schedule a meeting.

Ed Kelley, PhD
Chief Global Health Officer

Bo Kowalczyk
Chief Commercial Officer
